MedPath

Vertebral Technologies, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:0

Trial Phases

1 Phases

Phase 4:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 4
1 (100.0%)

A Prospective Study of the InterFuse T(tm),

Phase 4
Conditions
Low Back Pain
First Posted Date
2016-02-09
Last Posted Date
2016-11-02
Lead Sponsor
Vertebral Technologies, Inc.
Target Recruit Count
60
Registration Number
NCT02678130
Locations
🇺🇸

Medical University of South Carolina, CHarleston, South Carolina, United States

InterFuse® S and T for the Treatment of Scoliosis, Spondylolisthesis and Degenerative Disc Disease (DDD)

Conditions
Scoliosis
Back Pain
First Posted Date
2016-01-20
Last Posted Date
2016-11-02
Lead Sponsor
Vertebral Technologies, Inc.
Target Recruit Count
200
Registration Number
NCT02659722
Locations
🇺🇸

SUNY Upstate, Syracuse, New York, United States

A Pilot Study of the InterCushion Disc Nucleus Prosthesis (DNP) in Patients Receiving Discectomy

Conditions
Disk, Herniated
First Posted Date
2012-07-27
Last Posted Date
2016-11-02
Lead Sponsor
Vertebral Technologies, Inc.
Target Recruit Count
100
Registration Number
NCT01652053
Locations
🇨🇦

Brandon Regional Health Center, Brandon, Manitoba, Canada

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.